Therapeutic Development Community Call: Intellectual Property in Drug Discovery and Development Projects
This Therapeutic Development Learning Community session will explore balancing the drive for open science with the need to protect key aspects of a scientist’s work if the goal is one day to have developed a new therapeutic, diagnostic or medical device.
Therapeutic Development Community Co-Chairs
- Maaike Everts, PhD, Executive Director, TRxA – the Translational Therapeutics Accelerator Program Critical Path Institute
- Mary O’Reilly, PhD, VP Bioscience Research, Flinn Foundation